Replies to post #24239 on BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

The end game should be candor and honesty, so that the shareholders can make an informed decision on the merger. However if this is not an option for tactical reasons, then I may have come up with a win-win solution.

Since Biosante and ANI have been complicit in this deal and both are recommending it as being in the best interests of shareholders. Lets see them put their money where their mouth is.

Without full candor, the following idea may actually be a win - win scenario and allow the merger to go through with our support.

They should agree to put 50% of the shares that were to be awarded to ANI share holders,as well as 50% of the golden parachute and all other deal incentives in escrow. Since most ANI share holders are locked up for 6 months, this should not pose a problem. At the end of 6 months an independent assessor with no affiliation to ANI , Biosante or any of their backers should determine how the 50% of stock and money held in escrow should be distributed. If the merged company fails to meet their end of the bargain (i.e., screwing Biosante shareholders over), then present day Biosante shareholders (prior to merger) get a fair portion of the escrow shares and cash delivered to them.

If the period to execute their plan takes one year then maybe portions of the escrow can be release at 6 months and the remainder at the 1 year mark.

This would provide insurance and fairness to the process. If it is good enough for professional sports, why not a merger?

Obviously, if they will not agree to such a proposal. Then we are right in our assumption that they are trying to screw over present day Biosante shareholders and in fact the merger is not in the best interest of today's Biosante shareholders.

[Just the facts maam]

Rgshredder, we must not forget that Abbott or Abbvie are not the only Big Pharma with an interest in Testosterone replacement therapy.

Bayer ($117 Billion market cap) would be a very good partner, as well. They own the rights to Androgel outside the US, under the name Testogel.

In addition look at the Phase II trial

Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido

They are using two products for the same effect that Pill Plus does in one drug.

Phase II trial

Not to mention P&G, Warner Chilcott etc...

Given the fact that Abott and Abbvie has spent money and time developing Libigel guiding the trial. This is obviously something Abbott and Abbvie want to contain. However their greed may catch up with them.

Come to think of it, maybe that is who we should be directing the information we have collected. Biosante claims they have had many tire kickers but no firm offers. Well did they detail the car before putting a for sale sign on it? Did they let them look under the hood?

I think, I will send our finding to Bayer, etc... who knows it could very well spark some honest interest. Worth a shot at the very least.